Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

PRIMO 2023 | Recognizing the need to improve ovarian cancer cure rates

Alexander Olawaiye, MD, FRCOG, FACOG, FACS, University of Pittsburgh, Pittsburgh, PA, describes unmet needs in ovarian cancer, including the inability to diagnose ovarian cancer at early stages. Most patients are diagnosed at stage III/IV, and earlier diagnosis will enhance survival rates. Despite the introduction of PARP inhibitors, only one in five patients are cured, and novel treatment strategies are consequently needed. This interview took place at the Practical Recommendations in Immuno and Molecular Oncology (PRIMO) 2023 Congress in Honolulu, HI.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.